AVAH Stock Up 92% after 5-Day Win Streak
Aveanna Healthcare (AVAH) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 92% return. The company has gained about $1.3 Bil in value over the last 5 days, with its current market capitalization at about $1.4 Bil. The stock remains 58.4% above its value at the end of 2024. This compares with year-to-date returns of 9.6% for the S&P 500.
AVAH provides private duty nursing, home health and hospice, pediatric therapy, and enteral nutrition services through three specialized segments. After this rally, is AVAH still a buy – or is it time to lock in gains? Deep dive with Buy or Sell AVAH.
Comparing AVAH Stock Returns With The S&P 500
The following table summarizes the return for AVAH stock vs. the S&P 500 index over different periods, including the current streak:
- Vertiv Stock: Betting on Power and Heat In The AI Era
- Micron Stock: Up 170% And Still Cheap?
- Why On Earth Is SpaceX Worth $800 Billion?
- The Next Big Rally in Ford Motor Stock Could Start Like This
- The Risk Factors to Watch Out For in NVIDIA Stock
- Intuitive Surgical Stock Now 16% Cheaper, Time To Buy
| Return Period | AVAH | S&P 500 |
|---|---|---|
| 1D | 6.0% | 1.1% |
| 5D (Current Streak) | 91.5% | 2.3% |
| 1M (21D) | 77.9% | 2.8% |
| 3M (63D) | 25.3% | 10.3% |
| YTD 2025 | 58.4% | 9.6% |
| 2024 | 70.5% | 23.3% |
| 2023 | 243.6% | 24.2% |
| 2022 | -89.5% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has AVAH behaved after prior drops? See AVAH Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 84 S&P constituents with 3 days or more of consecutive gains and 40 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 43 | 25 |
| 4D | 23 | 14 |
| 5D | 10 | 0 |
| 6D | 1 | 1 |
| 7D or more | 7 | 0 |
| Total >=3 D | 84 | 40 |
Key Financials for Aveanna Healthcare (AVAH)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $1.9 Bil | $2.0 Bil |
| Operating Income | $113.7 Mil | $141.3 Mil |
| Net Income | $-134.5 Mil | $-10.9 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $559.2 Mil | $589.6 Mil |
| Operating Income | $51.9 Mil | $83.4 Mil |
| Net Income | $5.2 Mil | $27.0 Mil |
While AVAH stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.